Cyclic adenosine 3′,5′-monophosphate inhibits insulin-like growth factor I gene expression in rat glioma cell lines: Evidence for regulation of transcription and messenger ribonucleic acid stability

Endocrinology

Volumn 142, Issue 7, 2001, Pages 3041-3050

  Wang, Lai ^a   Adamo, Martin L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; EXON; GENE EXPRESSION; GLIOMA CELL; HALF LIFE TIME; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS INHIBITION; RAT; RNA STABILITY; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

EID: 0034988823     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.7.8224     Document Type: Article

References (48)

1. Cyclic AMP and adenyl cyclase in brain tumors
2. Increased intracellular cyclic AMP levels suppress the mitogenic responses of human astrocytoma cells to growth factors
3. Differential effects of cAMP in neurons and astrocytes. Role of B-raf
4. Induction of some features of glial differentiation in primary cultures of human gliomas by treatment with dibutyrl cyclic AMP
5. Glial fibrillary acidic protein in monolayer cultures of C-6 glioma cells: Effect of aging and dibutyryl cyclic AMP
6. Cyclic AMP blocks expression of the c-sis gene in tumor cells
7. The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma
8. Radioimmunoassay of insulin-like growth factors in cyst fluid of central nervous system tumors
9. Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; In vivo studies using in situ hybridization and immunocytochemistry
10. Characterization of insulin-like growth factor 1 in human primary brain tumors
11. Rat brain tumor models in experimental neuro-oncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 Gliomas
12. Regulation of insulin-like growth factor I production in rat C6 glioma cells: Possible role as an autocrine/paracrine growth factor
13. Prostaglandin A2 specifically represses insulin-like growth factor-I gene expression in C6 rat glioma cells
14. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I
15. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors
16. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors
17. Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA
18. Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells
19. Mutant IGF-I receptors as dominant negatives for growth and transformation
20. Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells
21. Independent control of the production of insulin-like growth factor I and its binding protein by cultured testicular cells
22. Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures
23. A role for protein kinases in the growth hormone regulation of cytochrome P4502C12 and insulin-like growth factor-I messenger RNA expression in primary adult rat hepatocytes
24. Gonadotropins induce accumulation of insulin-like growth factor I mRNA in pig granulosa cells in vitro
25. Human chorionic gonadotropin decreases insulin-like growth factor-I gene transcription in rat Leydig cells
26. 2
27. Insulin-like growth factor I messenger ribonucleic acid expression in porcine thyroid follicles is regulated by thyrotropin and iodine
28. Parathyroid hormone-related protein enhances insulin-like growth factor-I expression by fetal dermal fibroblasts
29. CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-1 gene transcription in osteoblasts
30. 3 cells: Evidence for an effect on IGF-I mRNA stability
31. Cell density influences IGF-I gene expression in a cell-type specific manner
32. Approaches for the purification, quantitation, and analysis of hormone and receptor mRNAs
33. Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms
34. Investigation of insulin-like growth factor (IGF)-I and insulin receptor binding and expression in jejunum of parenterally fed rats treated with IGF-I or growth hormone
35. The comparative analysis of methods to measure IGF-I in human serum
36. Radioimmunoassay for insulin-like growth factor-I: Solutions to some potential problems and pitfalls
37. Identification of newly transcribed RNA
38. Two putative GATA motifs in the proximal exon 1 promoter of the rat insulin-like growth factor I gene regulate basal promoter activity
39. The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism
40. Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo
41. Regulation of insulin-like growth factor I transcription by cyclic adenosine 3′,5′-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: Protein kinase A-dependent control without a consensus AMP response element
42. Cyclic AMP-mediated induction of the glial fibrillary acidic protein is independent of protein kinase A activation in rat C6 glioma
43. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
44. A family of cAMP-binding proteins that directly activate Rap1
45. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes
46. Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation
47. Insulin-like growth factors and their binding proteins: Biological actions
48. Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas